Odyssey Health, Inc. (ODYY): R&D Expense
$0
Year ended 2025-07-31
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-07-31 | $0 | -100.0% | 2025-10-29, From 2024-08-01 |
| 2024-07-31 | $55.2K | n/a | 2025-10-29, From 2023-08-01 |
| No annual figure between 2021-07-31 and 2024-07-31. | |||
| 2021-07-31 | $1.63M | n/m | 2021-10-29, From 2020-08-01 |
| 2020-07-31 | $20.2K | -99.9% | 2021-10-29, From 2019-08-01 |
| 2019-07-31 | $23.01M | n/a | 2020-11-16, From 2018-08-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Odyssey Health, Inc. (ODYY) | 2025-07-31 | $0 | -100.0% |
| ALR Technologies SG Ltd. (ALRTF) | 2025-12-31 | $793.3K | -10.2% |
| RetinalGenix Technologies Inc. (RTGN) | 2025-12-31 | $83.0K | -77.8% |
| Global Innovative Platforms Inc. (GIPL) | 2025-09-30 | $382.8K | n/m |
| Sigyn Therapeutics, Inc. (SIGY) | 2024-12-31 | $773.3K | -3.1% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $10.0K | -35.0% |
| Vivos Inc (RDGL) | 2025-12-31 | $352.2K | +8.5% |
| QHSLab, Inc. (USAQ) | 2025-12-31 | $484.9K | +64.7% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $2.65M | +14.8% |
Compare ODYY, ALRTF, RTGN, GIPL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗